MARKET

NGNE

NGNE

Neurogene
NASDAQ
30.44
+0.29
+0.96%
After Hours: 30.44 0 0.00% 16:00 02/26 EST
OPEN
29.76
PREV CLOSE
30.15
HIGH
30.93
LOW
29.76
VOLUME
77.63K
TURNOVER
0
52 WEEK HIGH
34.73
52 WEEK LOW
2.450
MARKET CAP
390.35M
P/E (TTM)
-0.5818
1D
5D
1M
3M
1Y
5Y
Neurogene Names Cochener SVP with Competitive Compensation Package
TipRanks · 5d ago
Weekly Report: what happened at NGNE last week (0212-0216)?
Weekly Report · 02/19 12:48
Weekly Report: what happened at NGNE last week (0205-0209)?
Weekly Report · 02/12 12:32
Stifel Nicolaus Keeps Their Buy Rating on Neurogene (NGNE)
TipRanks · 02/09 13:28
Weekly Report: what happened at NGNE last week (0129-0202)?
Weekly Report · 02/05 12:45
Analysts’ Top Healthcare Picks: Kura Oncology (KURA), Privia Health Group (PRVA)
TipRanks · 01/31 05:40
Weekly Report: what happened at NGNE last week (0122-0126)?
Weekly Report · 01/29 12:27
Weekly Report: what happened at NGNE last week (0115-0119)?
Weekly Report · 01/22 12:34
More
About NGNE
Neoleukin Therapeutics, Inc. is a biopharmaceutical company. The Company is engaged in providing immunotherapies for cancer, inflammation and autoimmunity using de novo protein design technology. The Company uses sophisticated computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins. Its primarily focused on key cytokine mimetics, which it refers to as Neoleukin de novo cytokine mimetics. The Company operates through the research and development of de novo protein therapeutics using sophisticated computational algorithms and methods to address unmet medical needs. The Company's primary areas of focus are on oncology, inflammation, and autoimmunity. Its de novo protein design process uses a set of advanced computational algorithms and methods to design functional de novo proteins.

Webull offers Neurogene Inc stock information, including NASDAQ: NGNE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NGNE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NGNE stock methods without spending real money on the virtual paper trading platform.